Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer

di van Weerden, W M, Bangma, C, de Wit, R
Pubblicazione 2009

Neuroendocrine differentiation in human prostatic tumor models.

di Noordzij, M. A., van Weerden, W. M., de Ridder, C. M., van der Kwast, T. H., Schröder, F. H., van Steenbrugge, G. J.
Pubblicazione 1996

Development of seven new human prostate tumor xenograft models and their histopathological characterization.

di van Weerden, W. M., de Ridder, C. M., Verdaasdonk, C. L., Romijn, J. C., van der Kwast, T. H., Schröder, F. H., van Steenbrugge, G. J.
Pubblicazione 1996

Disconnecting the Yin and Yang Relation of Epidermal Growth Factor Receptor (EGFR)-Mediated Delivery: A Fully Synthetic, EGFR-Targeted Gene Transfer System Avoiding Receptor Activa...

di Schäfer, A., Pahnke, A., Schaffert, D., van Weerden, W.M., de Ridder, C.M.A., Rödl, W., Vetter, A., Spitzweg, C., Kraaij, R., Wagner, E., Ogris, M.
Pubblicazione 2011

Imaging heterogeneity of peptide delivery and binding in solid tumors using SPECT imaging and MRI

di Haeck, J. C., Bol, K., de Ridder, C. M. A., Brunel, L., Fehrentz, J. A., Martinez, J., van Weerden, W. M., Bernsen, M. R., de Jong, M., Veenland, J. F.
Pubblicato in EJNMMI Res (2016)

Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xen...

di Schroeder, Rogier P. J., van Weerden, W. M., Krenning, E. P., Bangma, C. H., Berndsen, S., Grievink-de Ligt, C. H., Groen, H. C., Reneman, S., de Blois, E., Breeman, W. A. P., de Jong, M.
Pubblicazione 2011

A Transductionally Retargeted Adenoviral Vector for Virotherapy of Her2/neu-Expressing Prostate Cancer

di Magnusson, M.K., Kraaij, R., Leadley, R.M., De Ridder, C.M.A., van Weerden, W.M., Van Schie, K.A.J., Van der Kroeg, M., Hoeben, R.C., Maitland, N.J., Lindholm, L.
Pubblicazione 2012